ACRO Biomedical monthly revenue
ACRO Biomedical
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0B | +53.6% | +502.0% | NT$0B |
| May 2026 | Jun 17, 2026 | NT$0B | -9.1% | +290.9% | NT$0B |
| Apr 2026 | May 17, 2026 | NT$0B | +17.9% | +360.9% | NT$0B |
| Mar 2026 | Apr 17, 2026 | NT$0B | +18.4% | +58.1% | NT$0B |
| Feb 2026 | Mar 17, 2026 | NT$0B | +24.9% | +5.5% | NT$0B |
| Jan 2026 | — | NT$0B | — | -19.0% | NT$0B |
| Dec 2025 | — | NT$0B | — | -63.2% | NT$0B |
| Nov 2025 | — | NT$0B | — | +400.3% | NT$0B |
| Oct 2025 | — | NT$0B | — | -66.1% | NT$0B |
| Sep 2025 | — | NT$0B | — | -45.3% | NT$0B |
| Aug 2025 | — | NT$0B | — | -50.4% | NT$0B |
| Jul 2025 | — | NT$0B | — | -57.8% | NT$0B |
| Jun 2025 | — | NT$0B | — | -64.4% | NT$0B |
| May 2025 | — | NT$0B | — | -71.5% | NT$0B |
| Apr 2025 | — | NT$0B | — | -65.8% | NT$0B |
| Mar 2025 | — | NT$0B | — | -20.8% | NT$0B |
| Feb 2025 | — | NT$0B | — | -4.1% | NT$0B |
| Jan 2025 | — | NT$0B | — | +71.9% | NT$0B |
| Dec 2024 | — | NT$0B | — | -64.2% | NT$0B |
| Nov 2024 | — | NT$0B | — | +68.9% | NT$0B |
| Oct 2024 | — | NT$0B | — | +158.0% | NT$0B |
| Sep 2024 | — | NT$0B | — | -29.4% | NT$0B |
| Aug 2024 | — | NT$0B | — | +14.0% | NT$0B |
| Jul 2024 | — | NT$0B | — | +104.9% | NT$0B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-03-23. Source: Company websiteTaiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.